GE HealthCare Technologies Target of Unusually High Options Trading (NASDAQ:GEHC)

Key Points

• Investors bought 19,196 call options on GE HealthCare (a ~448% increase versus the typical ~3,502 daily calls), signaling unusually heavy bullish/speculative interest in the stock.
• GE HealthCare beat Q1 revenue ($5.13B) but missed on EPS ($0.99 vs. $1.07) and cut FY26 guidance to $4.80–$5.00, citing inflation, higher input costs and supply‑chain headwinds that are squeezing margins and weighing on the share price.
• Insider buys by CEO Peter Arduini (~4,169 shares) and director Frank R. Jimenez (~1,750 shares) point to management confidence even as analysts are mixed and the consensus rating remains a Hold.

GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) was the recipient of some unusual options trading activity on Friday. Investors purchased 19,196 call options on the stock. This represents an increase of 448% compared to the average daily volume of 3,502 call options.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on GEHC shares. UBS Group cut shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and increased their price objective for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Bank of America increased their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a "neutral" rating in a research note on Monday, January 5th. Oppenheimer reissued an "outperform" rating and set a $85.00 target price on shares of GE HealthCare Technologies in a research note on Thursday. Piper Sandler dropped their price objective on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an "overweight" rating on the stock in a research note on Friday, April 17th. Finally, Stifel Nicolaus set a $80.00 price objective on shares of GE HealthCare Technologies in a research note on Wednesday. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Hold" and an average price target of $80.67.

GE HealthCare Technologies News Summary

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Insider buys: CEO Peter Arduini bought 4,169 shares (~$59.92 avg) and director Frank R. Jimenez bought 1,750 shares, signaling management confidence which can support the stock. Read More. Read More.
• Positive Sentiment: Unusual call buying: Large jump in call option volume (19,196 calls vs. typical ~3,500) suggests some traders are betting on a near‑term rebound or takeover of downside risk. (No direct article link available.)
• Positive Sentiment: Bullish coverage pieces highlight upside potential based on Q1 revenue growth and strategic positioning in imaging/diagnostics. Read More.
• Neutral Sentiment: Wells Fargo trimmed its price target (from $97 to $75) but kept an overweight stance — indicates upside remains vs. current levels but with tempered near‑term expectations. Read More.
• Neutral Sentiment: Operational changes: Management is reorganizing Imaging and Advanced Visualization into a new Advanced Imaging Solutions unit to improve execution — strategic but benefits may take quarters to materialize. Read More.
• Negative Sentiment: Guidance cut and margin pressure: Management lowered FY26 EPS to a $4.80–$5.00 range, citing inflation, higher chip/oil/freight costs and supply‑chain headwinds — the guidance cut is the primary reason for recent weakness. Read More.
• Negative Sentiment: Mixed Q1 results: Revenue beat (~$5.13B) but EPS missed ($0.99 vs. $1.07 est.) and margins contracted, reinforcing short‑term downside risk. Read More.
• Negative Sentiment: Analyst downgrades / PT cuts: Multiple firms (Citigroup, JPMorgan, others) trimmed targets or ratings (Citigroup to $65 neutral; JPMorgan trimmed to $65), signaling reduced near‑term expectations from sell‑side desks. Read More. Read More.
• Negative Sentiment: Litigation inquiry: A shareholder law firm (Johnson Fistel) announced an investigation into executive conduct, adding headline and legal risk that may increase volatility. Read More.

GE HealthCare Technologies Stock Down 0.3%

Shares of GE HealthCare Technologies stock traded down $0.20 during trading hours on Friday, reaching $60.64. The company's stock had a trading volume of 4,390,542 shares, compared to its average volume of 3,891,638. The stock's fifty day simple moving average is $73.28 and its two-hundred day simple moving average is $77.52. The company has a market capitalization of $27.67 billion, a P/E ratio of 14.52, a P/E/G ratio of 1.34 and a beta of 1.17. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.13 and a current ratio of 1.22. GE HealthCare Technologies has a one year low of $58.75 and a one year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to analysts' expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts forecast that GE HealthCare Technologies will post 4.9 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies's dividend payout ratio is currently 3.35%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,750 shares of the firm's stock in a transaction on Thursday, April 30th. The stock was purchased at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the transaction, the insider owned 93,932 shares in the company, valued at $5,678,189.40. The trade was a 1.90% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Peter J. Arduini acquired 4,169 shares of the firm's stock in a transaction dated Thursday, April 30th. The shares were purchased at an average price of $59.92 per share, with a total value of $249,806.48. Following the completion of the transaction, the chief executive officer owned 259,424 shares of the company's stock, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.36% of the company's stock.

Institutional Trading of GE HealthCare Technologies

Several institutional investors and hedge funds have recently made changes to their positions in GEHC. Auto Owners Insurance Co raised its holdings in shares of GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company's stock valued at $278,725,000 after purchasing an additional 33,629,559 shares during the last quarter. Norges Bank purchased a new stake in GE HealthCare Technologies during the fourth quarter worth about $596,024,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter worth about $533,655,000. Capital Research Global Investors increased its holdings in GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company's stock worth $1,875,400,000 after buying an additional 4,998,154 shares during the last quarter. Finally, Cynosure Group LLC increased its holdings in GE HealthCare Technologies by 21,045.4% during the fourth quarter. Cynosure Group LLC now owns 4,365,462 shares of the company's stock worth $358,055,000 after buying an additional 4,344,817 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.